Cadmus C. Rich
2021
In 2021, Cadmus C. Rich earned a total compensation of $2.4M as Chief Medical Officer and Head of Research & Development at Aura Biosciences, a 279% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $154,002 |
|---|---|
| Option Awards | $1,466,906 |
| Salary | $392,816 |
| Stock Awards | $367,500 |
| Other | $17,400 |
| Total | $2,398,624 |
Rich received $1.5M in option awards, accounting for 61% of the total pay in 2021.
Rich also received $154K in non-equity incentive plan, $392.8K in salary, $367.5K in stock awards and $17.4K in other compensation.
Rankings
In 2021, Cadmus C. Rich's compensation ranked 5,318th out of 12,415 executives tracked by ExecPay. In other words, Rich earned more than 57.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,318 out of 12,415 | 57th |
Division Manufacturing | 2,236 out of 5,508 | 59th |
Major group Chemicals And Allied Products | 974 out of 2,378 | 59th |
Industry group Drugs | 868 out of 2,099 | 59th |
Industry Biological Products, Except Diagnostic Substances | 213 out of 449 | 53rd |
Source: SEC filing on April 28, 2022.
Rich's colleagues
We found two more compensation records of executives who worked with Cadmus C. Rich at Aura Biosciences in 2021.